MEA Peripheral Intravenous Catheters Market

The size of the Middle East and Africa Peripheral Intravenous Catheters market was around USD 0.47 Billion in 2022. It is expected to grow at a CAGR of 5.9% to reach USD 0.62 Billion by 2027. It captures 3% of the global market.

Increase in hospital and intensive care admissions due to the older population linked with numerous chronic and lifestyle diseases, expanding awareness of minimally invasive surgeries, and increased use of advanced materials such as Teflon and polytetrafluoroethylene in products, the adoption of PIVCs are the factors expanding the market. In addition, the high prevalence of needlestick injuries also drives healthcare providers to utilize drug delivery systems that lower the risk of needlestick injuries while also improving patient comfort. As a result, the surge in needlestick injuries encourages safer devices, boosting the market for Middle East Africa peripheral intravenous catheters.

One of the other significant factors projected to accelerate the growth and demand of the peripheral intravenous (IV) catheter market is the growing popularity of integrated peripheral intravenous catheters among the general population. Furthermore, the rise in the prevalence of chronic diseases, the aging of people, and advancements in surgery and treatment technologies contribute to the market's growth. The expanding patient population and hospital admissions, combined with the development of chronic diseases, have placed an additional load on the healthcare system in managing the provision of fluids and medications to patients. The development of PIVCs has alleviated this burden and the danger of complications associated with their use.

The high cost of peripheral intravenous (IV) catheters and various complications associated with peripheral intravenous catheters are expected to restrain the growth of the peripheral intravenous (IV) catheter market. In addition, the peripheral intravenous catheter market is projected to be hampered by complications connected with the peripheral intravenous catheter and a lack of training for the use of peripheral IV catheters.

This research report on the MEA peripheral intravenous catheters market has been segmented and sub-segmented into the following categories:

• By Product: Short PIVC (Ported Peripheral Intravenous Catheter and Non-ported Peripheral Intravenous Catheter) and Integrated/Closed PIVC   
• By Type: Integrated/Closed catheters and Peripheral insertion catheters     
• By End User: Hospitals, Clinics, Ambulatory Surgery Centers (ASCs), Home Use and Others   
• By Technology: Conventional Peripheral Intravenous Catheter and Safety Peripheral Intravenous Catheter
• By Country: KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA

To achieve a more significant market share, companies in the PIVC market concentrate on geographic expansion and consolidation of current manufacturing capabilities. To improve their market position and generate sustainable positioning, big pharma companies are focusing on acquiring local distributors and developing manufacturing footprint in Middle East Africa. South Africa has the minimum share among others. As essential products, vascular access accessories have inelastic prices. Because these products have such a small profit margin, competition is tough. Unfavorable price cuts are likely to result in price wars and a reduction in producer margins in such a scenario. The wider the distribution channel, it appears, the greater the profit potential. Catheterization will continue in high demand in hospitals, healthcare centers, ambulatory surgery centers, clinics, and home healthcare units as illness prevalence and infection rates rise. The increasing frequency of disease outbreaks is expected to demand peripheral intravenous catheters for patient evaluation, diagnosis, and treatment. Compared to other catheters, this is expected to include a higher percentage of PIVCs. The rising use of safety ported short peripheral intravenous catheters and the rise in the number of hospitalizations are expected to boost the market growth in this region. Furthermore, one of the significant factors projected to fuel the peripheral intravenous (IV) catheter development is increased awareness of improved possible treatments.

KEY MARKET PLAYERS:

Smith Medical, Terumo Corporation, C. R. Bard, Inc., Becton Dickinson and Company, B. Braun Melsungen AG, Tangent Medical, and Vygon Group are some prominent companies operating in the MEA peripheral IV catheters market.